Cyclothialidine analogs, novel DNA gyrase inhibitors (Q73477600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Cyclothialidine analogs, novel DNA gyrase inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Streptomyces filipinensis

1 reference

1 reference

(2S)-2-[[(5S,8S)-8-[[(2S,3R)-1-[(2S)-2-aminopropanoyl]-3-hydroxypyrrolidine-2-carbonyl]amino]-14,16-dihydroxy-7,11-dioxo-10-oxa-3-thia-6-azabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carbonyl]amino]propanoic acid

1 reference

1 reference

(2S)-2-[[(5S,8S)-8-[[(2S,3R)-1-[(2S)-2-aminopropanoyl]-3-hydroxypyrrolidine-2-carbonyl]amino]-14,16-dihydroxy-13-methyl-7,11-dioxo-10-oxa-3-thia-6-azabicyclo[10.4.0]hexadeca-1(16),12,14-triene-5-carbonyl]amino]propanoic acid

1 reference

inferred from

reverse claim

2-[[(5S,8S)-8-[[(2S,3R)-1-[(2S)-2-aminopropanoyl]-3-hydroxypyrrolidine-2-carbonyl]amino]-14,16-dihydroxy-7,11-dioxo-10-oxa-3-thia-6-azabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carbonyl]amino]acetic acid

1 reference

1 reference

(4S)-4-amino-5-[(2S,3R)-2-[[(5S,8S)-5-carbamoyl-14,16-dihydroxy-13-methyl-7,11-dioxo-10-oxa-3-thia-6-azabicyclo[10.4.0]hexadeca-1(16),12,14-trien-8-yl]carbamoyl]-3-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid

1 reference

1 reference

1 reference

K Yamaji

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Masubuchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Kawahara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Y Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Nishio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Matsukuma

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Fujimori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

N Nakada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Watanabe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Kamiyama

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

4 November 2019

publication date

1997

3 references

16 September 2022

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/50/5/50_5_402/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.402?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

402-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.50.402?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

The enantiomeric analysis of a mixture of all common protein amino acids by high-performance liquid chromatography using a new chiral mobile phase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Cyclothialidine, a novel DNA gyrase inhibitor. I. Screening, taxonomy, fermentation and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

DNA gyrase: an enzyme that introduces superhelical turns into DNA

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Proton magnetic resonance assignments of the polypeptide antibiotic telomycin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Biological characterization of cyclothialidine, a new DNA gyrase inhibitor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Crystallization of Inhibitor Complexes of an N-Terminal 24 kDa Fragment of the DNA Gyrase B Protein

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Cyclothialidine, a novel DNA gyrase inhibitor. II. Isolation, characterization and structure elucidation

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.47.37

Cloning of the DNA gyrase genes under tac promoter control: overproduction of the gyrase A and B proteins

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Amino acid analysis at the picomole level. Application to the C-terminal sequence analysis of polypeptides

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

A complete separation of dimethylaminoazobenzenesulphonyl-amino acids. Amino acid analysis with low nanogram amounts of polypeptide with dimethylaminoazobenzenesulphonyl chloride

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Inhibition of deoxyribonucleic acid gyrase: effects on nucleic acid synthesis and cell division in Escherichia coli K-12

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.50.402

Identifiers

DOI

10.7164/ANTIBIOTICS.50.402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9207910%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference